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Background: The study site started its roll-out of the human immunodeficiency virus (HIV) 
prevention of mother-to-child transmission in 2006. All patients were counselled by trained 
counsellors, before seeing a doctor. At the pharmacy the medicines were collected with no 
intense counselling by a pharmacist as the patients would have visited the trained counsellors 
first. Subsequently it was found that there were many queries regarding HIV and acquired 
immune deficiency syndrome (AIDS). Thus a dedicated antiretroviral pharmacy managed by 
a pharmacist was established to support the counsellors.
Objectives: The objective of the study was to assess the impact of a pharmacist intervention 
on the knowledge gained by HIV and AIDS patients with regard to the disease, antiretroviral 
drug use (i.e. how the medication is taken, its storage and the management of side effects) as 
well as adherence to treatment.
Method: This study was undertaken at a public sector hospital using anonymous structured 
questionnaires and was divided into three phases: pre-intervention, intervention and post-
intervention phases. After obtaining patient consent the questionnaires were administered 
during the first phase. A month later all patients who visited the pharmacy were counselled 
intensely on various aspects of HIV and antiretroviral medication. Thereafter patients who 
participated in Phase 1 were asked to participate in the second phase. After obtaining their 
consent again, the same questionnaire was administered to them. Quantitative variables were 
compared between pre-intervention and post-intervention stages by using paired t-tests or 
Wilcoxon signed ranks tests. Categorical variables were compared using McNemar’s Chi- 
square test (Binary) or McNemar-Bowker test for ordinal variables.
Results: Overall the mean knowledge score on the disease itself had increased significantly 
(s.d. 6.6%), (p < 0.01), after the pharmacists’ intervention (pre-intervention was 82.1% and 
post-intervention was 86.3%). A significant improvement was noted in the overall knowledge 
score with regard to medicine taking and storage (p < 0.05) and the management of the side 
effects. There was a non-significant difference between the adherence in pre-intervention and 
in post-intervention (p = 0.077).
Conclusion: Pharmacists’ intervention had a positive impact on HIV infected patients’ HIV 
and AIDS knowledge on both the disease and on the antiretroviral drug use and storage.
© 2011. The Authors.
Licensee: AOSIS 
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Human immunodeficiency virus (HIV) remains a global health problem of unprecedented 
dimensions. Three decades ago this virus was unknown; yet it has already caused an estimated 25 
million deaths worldwide and has generated profound demographic changes in the most heavily 
affected countries.1
In the countries that are most heavily affected, HIV has reduced life expectancy by more than 
20 years, slowed economic growth, and deepened household poverty. In sub-Saharan Africa 
alone, the epidemic has orphaned nearly 12 million children under the age of 18. The natural age 
distribution in many national populations in sub-Saharan Africa has been skewed dramatically 
by HIV.1
Sub-Saharan Africa remains the region most heavily affected by HIV, accounting for 67% of all 
people living with HIV and for 75% of acquired immune deficiency syndrome (AIDS) related 
deaths in 2007.1
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In Southern Africa, South Africa is home to the world’s 
largest population of people living with HIV (5.7 million).1 
The prevalence of HIV in South Africa varies by province, 
with KwaZulu-Natal having the highest prevalence with 
15.8% of people affected by HIV.2
The South African Government’s response to the HIV 
and AIDS epidemic is found in the HIV and AIDS and 
STI Strategic Plan for South Africa of 2007–2011. The plan 
purposed to provide a broad national framework around 
four areas: 
•	 prevention and treatment 
•	 care and support 
•	 research, monitoring and evaluation 
•	 human and legal rights.3
HIV is present in the blood and genital secretions of virtually 
all infected individuals regardless of whether or not they 
have symptoms. The spread of HIV can occur when these 
secretions come into contact with tissues such as those lining 
the vagina, the anal area, mouth, or eyes, or a break in the 
skin, such as a laceration or a puncture by a needle.4 The 
transmission of HIV is normally via sexual contact, needle 
sharing, and transmission from infected mothers to their 
babies during pregnancy, labour or breast-feeding. Sexual 
transmission of HIV has been described from men to men, 
men to women, women to men and women to women 
through vaginal, anal and oral sex. The ideal to avoid sexual 
transmission would be abstinence from sex until it is certain 
that both partners, who are in a monogamous relationship, 
are not HIV infected. If abstinence is not possible then the use 
of condoms is encouraged. The spread of HIV by exposure 
to infected blood usually results from sharing needles, as in 
those used for illicit drugs. Unless there are open sores or 
blood in the mouth, kissing is generally considered not to be 
a risk factor for transmitting HIV.4
The mother-to-child transmission rate had increased at a 
phenomenally high percentage. Whereas in 1990, the HIV 
prevalence amongst pregnant women attending antenatal 
clinics in South Africa was less than 1%, the prevalence had 
risen 10 years later, in the year 2000, to 24.5% causing an 
estimated 550 000 children to be infected with the virus. 
In many low-resource settings, the most feasible regimen 
was intra-partum and post-partum Nevirapine, for reasons 
of cost and convenience. Nevirapine was advocated to be 
given to the mother as soon as possible after the onset of 
labour. Nevirapine decreased the incidence of transmission 
of HIV and AIDS from mother to child by 50%–70%.5 The 
introduction of HAART ((highly active antiretroviral therapy) 
had revolutionised the treatment of HIV and AIDS patients 
with regard to the management of HIV infected persons. 
These effectively inhibit viral replication, prevent drug 
resistance and prevent immune dysfunction. Antiretroviral 
drugs are arranged in five classes:
•	 nucleoside or nucleotide reverse transcriptase inhibitors 
(NRTIs)
•	 non-nucleoside reverse transcriptase inhibitors (NNRTIs)
•	 protease inhibitors (PIs)
•	 entry inhibitors
•	 integrase inhibitors.6
The HAART regimens comprise at least three drugs and 
require that numerous drugs be taken every day to achieve 
maximum viral suppression.7 Adherence to these drugs by 
HIV patients is therefore vital in order to achieve optimum 
therapeutic outcomes. Antiretroviral therapy can fail because 
of poor adherence, acquired drug resistance, poor drug 
absorption, drug-drug interactions or lack of drug potency.8 
Failure to take all of the prescribed doses of antiretroviral 
medication may result in inadequate drug concentrations, 
which can result in incomplete inhibition of HIV replication 
and may accelerate viral resistance to antiretroviral therapy.9
Antiretroviral medication must be stored correctly in order 
to remain potent and to have the desired pharmacological 
effect. Drugs such as Lamivudine, Zidovudine, Stavudine, 
Nevirapine and Efavirenz should be stored below 25˚C in 
a cool, dry place and should be protected from moisture 
and light, whilst Kaletra® is stable until the expiry date if 
refrigerated or kept for 2 months at room temperature.10
The public sector roll-out programme in South Africa for the 
prevention of mother-to-child transmission with Nevirapine 
started at 18 pilot sites in 2000. An antiretroviral (ARV) 
treatment plan was published in 2003 and the roll-out of 
antiretroviral treatment started at 32 accredited sites in April 
2004, aiming to treat all South Africans that needed therapy.11
Some drugs cannot be given concomitantly; many drugs 
alter the concentration of others, resulting in toxic and sub-
therapeutic effects, thereby demanding a change in dosage 
of one or more medications. Some oral medication should 
be given with food12 or cannot be taken with certain foods, 
some on an empty stomach, and many have to be taken on 
a very specific schedule so that the drug’s concentration in 
the bloodstream does not vary.13 Some medication should 
not be co-administered with other medication whilst 
certain medication will cause therapeutic failure.12 It is the 
responsibility of the pharmacist to ensure that the patient 
and caregivers are aware of these dietary restrictions.14
The ARV clinic at the study site was in operation since 
October 2006. Prior to the study conducted, all patients were 
counselled by trained counsellors on three consecutive visits 
to the ARV clinic, before being seen by a doctor for the first 
time. Then the patients would go to the ARV pharmacy 
where pharmacists would hand over the medication, 
explaining only when and how often patients have to take the 
medication. No intense counselling on the ARV medication 
was conducted.
Subsequently it was found that there were many queries 
from patients attending the HIV clinic regarding knowledge 
on the disease, how it is transmitted, and the measures that 
can be taken to prevent HIV infection. Other queries related 
to the medication, its side effects, storage conditions and so 
forth. A decision was made to establish the ARV pharmacy 
and to have it managed by a dedicated ARV pharmacist who 
would support the counsellors by reinforcing what was said 
by counsellors, as well as giving detailed information on their 
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disease condition, HIV prevention methods, medication, side 
effects, and medication storage.
Pharmacists are often considered the most accessible health 
professional14 whose core function is the provision of 
pharmaceutical care, in essence the responsible provision of 
drug therapy for the purpose of achieving definite outcomes 
which improve the patients’ quality of life.15 Overall, 
the pharmacists’ responsibility is to optimise a patient’s 
medication therapy.14 Amongst the many medical conditions 
that pharmacists deal with are HIV and AIDS.
As of from May 2007, pharmacists were expected to dispense 
ARV medication and counsel the patients. This study 
was subsequently undertaken to assess the impact of a 
pharmacist’s intervention on the knowledge gained by HIV 
and AIDS patients with regard to the disease, antiretroviral 
drug use (that is, how the medication is taken, its storage 
and the management of side effects) as well as adherence to 
treatment.
Ethical consideration
Ethical approval to conduct this study was obtained from the 
University of KwaZulu-Natal Research and Ethics Committee 
(Ethics Number: FECHSC 002/07). Permission to administer 
the questionnaire to patients was obtained from the senior 
management of the study site and the Provincial Department 
of Health in KwaZulu-Natal. Anonymity of responses was 
maintained by requesting participants not to disclose their 
personal details on the questionnaires.
Method
Setting and material
The study was undertaken at a public sector hospital 
(Community Health Centre) at which the principal 
investigator was based during October 2007 and November 
2007. This Community Health Centre is situated in the 
Northern Suburb of the eThekwini Metro of KwaZulu-Natal. 
The HIV clinic at the study site sees people of different 
cultures, religious denominations and races. All HIV infected 
patients who visited the clinic during the time period of 
October 2007 to November 2007 were invited to participate 
in the study, in total a number of 400 patients.
Design
This was an intervention study divided into three phases: 
a Pre-intervention Phase (Phase 1), an Intervention Phase 
(Phase 2), and a Post-intervention Phase (Phase 3). There was 
no control group as participants acted as their own controls 
in the pre-intervention phase.
Pre-intervention Phase (Phase 1)
During their clinic visit in the study period, the study 
was explained to each participant and a consent form 
was completed. A pre-tested questionnaire which was 
anonymous and structured was handed to all participants in 
their language of choice. The questionnaire included sections 
on demographics, knowledge of medicines, the taking of 
medicine and disease conditions together with questions on 
storage, side effects experienced and adherence patterns.
On completion of the questionnaires, they were collected 
and coded. A register of these participants with their 
corresponding coding was opened and their details entered 
in the register.
Intervention Phase (Phase 2)
At the second visit, one month after Phase 1, all patients 
who visited the clinic were counselled by the pharmacist on 
all aspects of their medicines, medicine taking, and disease 
condition, together with information on storage, side effects 
experienced and the importance of adherence by helping 
patients plan dose times, explaining what to do if a dose was 
missed and suggesting ways to remember to take medication, 
as well as managing side effects.
Participants who took part in Phase 1 of the study were once 
again asked for consent to participate in Phase 2 of the study.
Post-Intervention phase (Phase 3)
The same questionnaire that was used in Phase 1 was filled 
out again by the participants who consented to be part of 
Phase 2. The register of the participants was destroyed after 
the completion of Phase 3 of the study in order to ensure 
confidentiality.
Analysing
The data were captured and analysed using SPSS (Statistical 
Package for the Social Sciences) version 15.0 (SPSS Inc., 
Chicago, Illinois, USA). Knowledge was scored by allocating 
a score of 1 to each correct answer, summing up the scores, 
and subsequently expressing the scores as a percentage of the 
total possible score with higher percentages indicating higher 
levels of knowledge. The changes in all factors between 
pre-intervention and post-intervention were assessed 
statistically. Quantitative variables were compared between 
pre-stages and post-stages using paired t–tests or Wilcoxon 
signed ranks tests. Categorical variables were tested using 
McNemar’s Chi-square test (Binary) or the McNemar-
Bowker test for ordinal variables.
Results
Response Rate
Two-hundred (50%) patients consented to be part of Phase 
1 of the study. In Phase 2, one hundred and seventy five 
patients completed the questionnaire. Thus 175 participants 
completed both phases of the study, resulting in a response 
rate of 87.5%.
The demographic profile of the participants is depicted in 
Table 1.
The majority of the patients were female. Almost 70% of 
the participants were in the age-range of 21–40 years old. 
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The majority of the participants did not have post-school 
education.
Respondents’ knowledge of HIV and AIDS
General HIV and AIDS knowledge
The general knowledge of the participants had increased 
with all but one question after the pharmacist’s intervention.
The question on whether HIV is a bacterium that causes AIDS 
was answered incorrectly by the majority of the participants 
(95.4%); however, there was a slight improvement with 
correct answers during the post-intervention phase.
The participants’ knowledge of whether people who have 
sexually transmitted diseases are least at risk of contracting 
the HIV virus, healthy food will cure HIV, and whether 
smoking and drinking alcohol will weaken the HIV virus, 
increased significantly from the pre-intervention phase to the 
post-intervention phase.
Knowledge on modes of transmission
The participants’ knowledge on the modes of transmission 
either increased or remained unchanged (Table 2 and 3). The 
majority of participants (94.6%) did not know that sexual 
contact with a homosexual with an unknown HIV status 
could result in a HIV infection.
Respondents’ knowledge on HIV prevention
The overall mean knowledge score, Pre-intervention, was 
82.1% with a standard deviation of 6.6%, whilst after the 
Intervention it had increased to 86.3% (SD 6.6%). This 
increase was statistically significant (Table 4 and 5).
Respondents knowledge on antiretroviral 
drug use
How medication is taken
The frequency of initially reporting taking Lamivudine, 
Stavudine and Efavirenz with a high fatty meal or any time 
they remembered decreased to zero after the Intervention. 
The majority of the patients took their medication either with 
food or without food at both phases of the study.
Respondents knowledge on storage of antiretroviral 
medication
In both phases, over 40% of all the patients stored their 
medication in a cupboard. There were no significant 
differences in terms of storage of the antiretroviral medication 
in both pre-intervention and post-intervention.
Some of the participants chose Other as their answer. Other 
referred to storage in the bedroom, drawers in the bedroom, 
a drawer in the dressing table, the headboard, in a box, in 
a bag, in a shoe box, in an underwear drawer, on top of a 
wardrobe and on shelves in the bedroom.
Management of side effects
When asked whether the side effects of the medication 
were explained to the participants, 98.3% (n = 172) said yes 
whilst 1.7% (n = 3) said no in the pre-intervention phase. This 
increased to 100% (n = 175) in the post-intervention phase.
In terms of participants’ understanding of medication and 
side effects, when they occur, 96% (n = 168) said they would 
go to a doctor or clinic immediately in the pre-intervention 
phase. This increased to 99.4% (n = 174) at post-intervention.
When asked what they would do if they vomited after taking 
their medication, 94.9% (n = 166) stated that they would take 
their medication again if they vomited less than 30 minutes 
after taking the medication, and at post-intervention this 
improved to 97.7% (n = 171). Furthermore, 92% (n = 161) said 
they would do nothing if they vomited more than 30 minutes 
after taking their medication pre-intervention whilst this 
improved to 96% post-intervention.
Overall the responses on drug storage, how the medication 
is taken, the management of side effects and what to do if 
vomiting occurs, were scored by assigning a score of 1 for 
each correct response. The maximum score was 5.
Respondents generally scored high, with the median score 
pre-intervention equal to 4 (inter-quartile range 4–5), whilst 
the median increased significantly to 5 (inter-quartile range 
4–5) (p = 0.024) in the post-intervention phase.
Adherence to treatment
Patients were counselled on adherence during the post-
intervention phase, but there was a non-significant difference 
in adherence pre-intervention and post-intervention 
(p = 0.077). Twelve participants improved their adherence 
from pre-intervention to post-intervention whilst in another 
four respondents the adherence to medicines worsened. 
Although this suggests an improvement trend, it could not 
be confirmed statistically.
Discussion
The respondents’ knowledge on HIV and AIDS (p < 0.001) 
and on medicine taking and storage (p < 0.05) had increased 
significantly after the intervention of the pharmacist. This 
TAblE 1: Demographic profile of participants (N = 175).
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Source: Authors’ original data
n, Number of participants.
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suggested that the pharmacist did make a positive impact on 
the knowledge of the HIV infected patients who attended the 
public sector facility where the study was carried out.
In terms of the specific questions asked on general 
knowledge, most of the participants knew about the disease 
with the exception of the question that related to HIV being 
a bacterium that causes AIDS, where a very small percentage 
knew the correct answer.
One possible reason could be that the participants may not 
have known that there is a difference between a bacterium 
TAblE 2: Respondents’ general knowledge of HIV and AIDS (N = 175) for Pre-intervention and Post-intervention.
Question Intervention %
Pre Post
HIV is a bacterium which causes AIDS 4.6 6.3
People with AIDS cannot fight sicknesses such as diarrhoea, TB and pneumonia 61.7 46.3
The HIV virus attacks the heart and liver 49.1 53.1
You can tell from a person’s appearance that they have the HIV virus 80.5 91.4
A person has less chance of being infected with the HIV virus if they have one partner 84.0 89.7
A person can become infected with the HIV virus if they have unprotected sex with someone who has HIV 97.1 98.9
People who have sexually transmitted infections (STIs) are the least at risk of becoming infected with the HIV virus 35.4 61.1
Not all babies whose mothers are HIV positive, are born with the virus 89.7 91.9
Healthy food will cure HIV 52.9 86.3
Smoking and drinking alcohol will strengthen the body 98.3 98.3
Smoking and drinking alcohol will weaken the HIV virus 68.0 93.1
Support groups cannot help people with HIV and AIDS to deal with anger and loneliness 80.6 93.7
Diarrhoea is when you pass two or more loose or watery stools a day 93.1 94.9
When a person starts to cough, cough mixtures to stop the cough can be taken 63.4 84.0
People with HIV and AIDS have problems with their skin, for example rash 97.1 98.3
A person can be re-infected with HIV 92.6 95.4
Antiretroviral medication is a complete cure for HIV and AIDS 87.4 88.6
Source: Authors’ original data
N, Number of participants; TB, Tuberculosis.
TAblE 3: Respondents’ knowledge of the modes of transmission: Pre-transmission and Post-transmission (N = 175).
Modes of Transmission Intervention %
Pre Post
Sharing needles with a person infected with HIV and AIDS 97.7 99.4
Unprotected sexual contact with a person infected with HIV and AIDS 99.4 100.0
Contact with blood 98.3 98.3
Sharing toilet seats with a person infected with HIV and AIDS 93.1 95.4
Using the same eating and drinking utensils of a person infected with HIV and AIDS 95.4 96.0
Kissing a person infected with HIV and AIDS who has sores in his or her mouth 84.0 87.4
Touching a HIV patient 94.9 94.9
Being bitten by a mosquito 68.6 75.4
Sexual contact with a homosexual with an unknown HIV status 15.4 15.4
Working with a person infected with HIV and AIDS 96.6 96.0
Sexual contact with too many partners with an unknown HIV status 92.0 97.1
Source: Authors’ original data
N, Number of participants.
TAblE 4: Respondents’ knowledge of HIV prevention; Pre-intervention and Post-intervention (N = 175).
HIV Prevention Intervention %
Pre Post
Abstinence from sex 93.7 94.9
The use of latex barriers (condoms) 97.7 97.1
Avoiding needle sharing 98.9 98.3
By being faithful to one partner 97.1 96.0
By not associating with HIV and AIDS patients 91.4 92.6
Source: Authors’ original data
N, Number of participants.
TAblE 5: Paired t-test for the comparison of mean knowledge score Pre-intervention and Post-intervention.
Paired t-test Mean N STI Deviation STI Error Mean p-value
knowledge score Pre-intervention 82.10 175 6.598 0.499 < 0.001*
knowledge score Post-intervention 86.35 175 6.628 0.501 -
Source: Authors’ original data
N, Given as means of Total number; STI, Sexual Transmitted Infection.
*, p = 0,000.
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and a virus as over 92% of them did not have post-school 
education. 
The second possible reason, however, based on the fact that 
the pharmacist counselled the patients, could be that those 
respondents still believed that HIV (irrespective of whether 
it is a bacterium or a virus) does not cause AIDS. This belief 
could have been influenced by the dissident view shared by 
the previous South African President, Mr Thabo Mbeki, who 
stated that HIV was not responsible for AIDS.16,17
With regard to sexually transmitted infections as a risk to 
contract HIV, just over a third of the respondents gave the 
correct answers. After the intervention, however, about two-
thirds of the respondents displayed a greater knowledge 
about sexually transmitted infections and HIV infection. This 
finding is also supported by a study carried out in Ghana 
where it was found that pharmacists played a crucial role in 
the effective management of sexually transmitted infections.18
Another study carried out amongst high school students in 
Kathmandu Valley, found that pre-education knowledge 
of sexually transmitted infections was quite low (41.7%) 
compared to post-education knowledge (87.2%).19
Smoking and drinking alcohol were perceived by some of 
the respondents as a means of weakening the virus with only 
68% of the respondents answering this question correctly 
before the intervention of the pharmacist. Even though this 
number greatly increased after the intervention, a small 
percentage (6.9%) still believed that smoking and drinking 
alcohol does have an effect on the virus. This could be one 
of the reasons why smoking and alcohol consumption are so 
common amongst HIV infected individuals as studies have 
shown.20 Other studies have shown that smoking and alcohol 
consumption amongst HIV positive individuals is high, 
attributing this to the stress caused by HIV status disclosure. 
Many patients also believed that to quit smoking would not 
improve their health.21
In this study a small percentage, both pre-intervention 
and post-intervention (12.6% and/or 11.4%), were of the 
opinion that AIDS could be cured. This correlated to a study 
conducted in Malaysia amongst young Malaysian adults 
where it was found that 18.1% believed that there was a cure 
for AIDS.22
A majority of the study population knew how HIV was 
transmitted with a further increase in the numbers knowing 
the different modes of transmission after the pharmacist’s 
intervention. The percentage, however, that responded to the 
question on whether sexual contact with a homosexual with 
an unknown HIV status can cause AIDS, remained the same in 
both the pre-intervention and post-intervention phases, even 
though the pharmacist counselled them. A possible reason 
could be that the terminology ‘homosexual’ had been used 
and not the common terminology ‘gay’, which could lead 
to confusion amongst respondents as to the interpretation 
of the question, with an accompanying reluctance to asking 
for clarification. Some patients may feel embarrassed to ask 
questions. Studies have shown that patients are afraid to ask 
or request an explanation of terms or questions for fear of 
being ridiculed, fear of the illness and treatment or fear of the 
doctor; in this case it could be the researcher.23
Almost a third of the respondents believed that a mosquito 
bite could transmit the virus; however, of concern is that 
even after the intervention, a quarter of the respondents still 
maintained this belief. The belief that mosquitoes are vectors 
for HIV is a quite common misconception that has been 
shown in other studies as well.24
A further concern was that even though the respondents 
were counselled by the pharmacist and there was a positive 
outcome, there were still a small percentage of respondents 
that stuck to their own beliefs. With the exception of 
whether the act of unprotected sex can transmit the virus, 
the other responses in the post intervention phase did not 
give a 100% positive response to the questions. Of concern 
were questions on transmission (namely, via contact with 
blood, kissing of HIV infected persons with sores in their 
mouths, sexual contact with too many partners of unknown 
status could lead to risky behaviour) which implied that if 
respondents did not accept these means of possible modes 
of transmission, it could lead to a progression in the spread 
of the virus. Additional education on the different modes of 
transmission is consequently essential in order to prevent 
further transmission so that the epidemic can be contained.
Over 91% of the respondents were familiar with HIV 
prevention methods as they answered correctly to the 
questions given. A small percentage, however, still clung to 
the same views or beliefs even after the intervention. They 
maintained that abstinence from sex, the use of condoms, 
being faithful to one partner and so forth, would not 
contribute to HIV prevention methods. The finding relating 
to condom use correlates to another study where it was 
found that only 79.5% knew that HIV could be prevented by 
using condoms.22
Even though 12 participants improved adherence from 
pre-intervention to post-intervention in this study and 
although it was not statistically significant, there has been 
an improvement with the intervention of the pharmacist. 
This can be likened to a USA-based study where it was 
demonstrated that few non-compliant patients obtained 
an undetectable viral load prior to the pharmacists’ 
intervention. However, a significantly higher proportion of 
patients achieved an undetectable viral load after attending 
a pharmacist counselling clinic. In treatment experienced 
patients, the incorporation of a pharmacist in the HIV care 
team had a significant impact on patient outcomes.25
Pharmacist intervention resulted in an improved response in 
terms of side effects, from the pre-intervention to the post-
intervention phases.
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Pharmacists played a positive role in the way patients took 
their medication with regard to food. Most patients would 
avoid taking their medication with a high fatty meal after 
the intervention and took their medication correctly either 
with or without food. This is important because food can 
affect the absorption, metabolism, distribution and excretion 
of antiretroviral medication. Important interactions include 
that of Efavirenz with a high fatty meal, which should be 
avoided because of a reduced drug absorption.26
Respondents chose a variety of storage places for their 
antiretroviral medication, such as the bedroom, drawers in 
the bedroom, a drawer in the dressing table, the headboard, 
a box, a bag, a shoe box, an underwear drawer, on top of a 
wardrobe and shelves in the bedroom. This was of interest 
because it gave the impression that patients hid their 
medication. It could have been because patients did not want 
anyone to know their HIV status and because HIV is associated 
with stigma and discrimination. These individuals, if found 
out to be HIV positive, could face rejection by their families 
and communities.27 AIDS-related stigma and discrimination 
can also directly hamper the effectiveness of AIDS responses. 
Stigma and discrimination can directly affect the likelihood 
of protective behaviours.28
limitations
Firstly, this intervention study was limited to patients who 
were willing to participate in the study. The sample size was 
relatively small because it was confined to one hospital, which 
is a community health centre. Secondly, the reliability and 
validity of the participants’ self-report was unknown. Another 
limitation was the poor response rate after the intervention 
phase, that is, 12.5% of the participants abandoned the study. 
This could have been because most patients did not want 
to spend time to complete the questionnaires because they 
might have been aware of the time it took to complete the 
questionnaire in the first phase and the answers required 
of them, and might not have felt comfortable to repeat the 
process. Another reason indicated by many patients was that 
they wanted to collect their medication and leave the clinic 
quickly because of transport problems and/or the need to 
return to the workplace. A few patients just mentioned that 
they were in a hurry.
Conclusion and recommendations
This study shows that a pharmacist-led intervention can 
bring about a significant improvement in the knowledge of 
HIV and AIDS patients regarding the HIV virus, its mode 
of transmission, prevention methods and antiretroviral 
medication use, storage as well as adherence to medication. 
Pharmacists play a crucial role in distributing AIDS-related 
information to the public and promoting the understanding 
of HIV and AIDS.
Pharmacists, whether in the public or private healthcare 
sector, should become more involved in the management 
of HIV infected patients and should play a pivotal role in 
the dissemination of HIV and AIDS information. The data 
from this research study could be a useful guide in the 
development of campaigns or programmes designed to 
convey accurate information about HIV and AIDS in terms 
of knowledge and adherence. Education based interventions 
may improve adherence to HAART. Interventions include 
patient education, counselling, health promotion, reminders 
and the provision of resources.
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